Graft-versus-host disease (GVHD) is a condition that can occur after an allogeneic transplant, where the donor's immune cells attack the recipient's tissues and organs. Symptoms range from mild to severe and can affect the skin, liver, gastrointestinal tract, and other organs. GVHD is managed with immunosuppressive medications, but it remains a significant complication of stem cell infusion.
